Library — CHDR

Search

Filter

[Practical guideline for the use of colistin].

Dijkmans AC, Wilms EB, Kamerling IM, Birkhoff W, van Nieuwkoop C, Verbrugh HA, Touw DJ

Nederlands tijdschrift voor geneeskunde, 2014 Sep

View publication
Fosfomycin: Pharmacological, Clinical and Future Perspectives.

Dijkmans AC, Zacarías NVO, Burggraaf J, Mouton JW, Wilms EB, van Nieuwkoop C, Touw DJ, Stevens J, Kamerling IMC

Antibiotics (Basel, Switzerland), 2017 Oct

View publication
How to expedite early-phase SARS-CoV-2 vaccine trials in pandemic setting-A practical perspective

Johan L van der Plas, Meta Roestenberg, Adam F Cohen, Ingrid M C Kamerling

Br J Clin Pharmacol, 2020 Sep

View publication
Pharmacokinetics of fosfomycin in patients with prophylactic treatment for recurrent Escherichia coli urinary tract infection.

Kuiper SG, Dijkmans AC, Wilms EB, Kamerling IMC, Burggraaf J, Stevens J, van Nieuwkoop C

The Journal of antimicrobial chemotherapy, 2020 Jul

View publication
Colistin: Revival of an Old Polymyxin Antibiotic.

Dijkmans AC, Wilms EB, Kamerling IM, Birkhoff W, Ortiz-Zacarías NV, van Nieuwkoop C, Verbrugh HA, Touw DJ

Therapeutic drug monitoring, 2015 Aug; 37(4):419-27

View publication
[Fosfomycin, an old antibiotic with new possibilities].

Dijkmans AC, Kuiper SG, Burggraaf J, Mouton JW, Wilms EB, Touw DJ, Stevens J, van Nieuwkoop C, Kamerling IMC

Nederlands tijdschrift voor geneeskunde, 2017 Sep

View publication
First-in-human administration of a live-attenuated RSV vaccine lacking the G-protein assessing safety, tolerability, shedding and immunogenicity: a randomized controlled trial.

Verdijk P, van der Plas JL, van Brummelen EMJ, Jeeninga RE, de Haan CAM, Roestenberg M, Burggraaf J, Kamerling IMC

Vaccine, 2020 Sep; 38(39):6088-6095

View publication
Controlled Human Infections As a Tool to Reduce Uncertainty in Clinical Vaccine Development.

Roestenberg M, Kamerling IMC, de Visser SJ

Frontiers in medicine, 2018 Oct

View publication
Prevalent levels of RSV serum neutralizing antibodies in healthy adults outside the RSV-season.

van der Plas JL, Verdijk P, van Brummelen EMJ, Jeeninga RE, Roestenberg M, Burggraaf J, Kamerling IMC

Human vaccines & immunotherapeutics, 2019 Nov

View publication

«
1
2
»